Human Xtensions Ltd (HUMX) - Net Assets
Based on the latest financial reports, Human Xtensions Ltd (HUMX) has net assets worth ILA3.29 Million ILA (≈ $8.81K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA4.39 Million ≈ $11.77K USD) and total liabilities (ILA1.10 Million ≈ $2.96K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check HUMX financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA3.29 Million |
| % of Total Assets | 74.83% |
| Annual Growth Rate | -24.32% |
| 5-Year Change | -98.04% |
| 10-Year Change | N/A |
| Growth Volatility | 250.7 |
Human Xtensions Ltd - Net Assets Trend (2018–2024)
This chart illustrates how Human Xtensions Ltd's net assets have evolved over time, based on quarterly financial data. Also explore HUMX total asset value for the complete picture of this company's asset base.
Annual Net Assets for Human Xtensions Ltd (2018–2024)
The table below shows the annual net assets of Human Xtensions Ltd from 2018 to 2024. For live valuation and market cap data, see market value of Human Xtensions Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ILA2.91 Million ≈ $7.81K |
-88.84% |
| 2023-12-31 | ILA26.11 Million ≈ $69.99K |
-57.74% |
| 2022-12-31 | ILA61.78 Million ≈ $165.63K |
-40.90% |
| 2021-12-31 | ILA104.53 Million ≈ $280.25K |
-29.76% |
| 2020-12-31 | ILA148.82 Million ≈ $398.99K |
+628.49% |
| 2019-12-31 | ILA20.43 Million ≈ $54.77K |
+31.76% |
| 2018-12-31 | ILA15.51 Million ≈ $41.57K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Human Xtensions Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 23551600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA267.00K | 9.17% |
| Other Components | ILA327.40 Million | 11239.20% |
| Total Equity | ILA2.91 Million | 100.00% |
Human Xtensions Ltd Competitors by Market Cap
The table below lists competitors of Human Xtensions Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Gabather AB (publ)
ST:GABA
|
$2.12 Million |
|
British Smaller Companies Vct 2 Plc
LSE:BSC
|
$2.12 Million |
|
Luxbright AB
ST:LXB
|
$2.12 Million |
|
Synthomer plc
LSE:SYNT
|
$2.12 Million |
|
Downing Renewables & Infrastructure Trust PLC
LSE:DORE
|
$2.11 Million |
|
Rainbow Rare Earths Limited
LSE:RBW
|
$2.11 Million |
|
Martello Technologies Group Inc
V:MTLO
|
$2.11 Million |
|
M&C Saatchi
LSE:SAA
|
$2.11 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Human Xtensions Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 26,106,000 to 2,913,000, a change of -23,193,000 (-88.8%).
- Net loss of 22,971,000 reduced equity.
- Other factors decreased equity by 222,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-22.97 Million | -788.57% |
| Other Changes | ILA-222.00K | -7.62% |
| Total Change | ILA- | -88.84% |
Book Value vs Market Value Analysis
This analysis compares Human Xtensions Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 270.21x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 3.01x to 270.21x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | ILA9.81 | ILA29.50 | x |
| 2019-12-31 | ILA0.77 | ILA29.50 | x |
| 2020-12-31 | ILA5.58 | ILA29.50 | x |
| 2021-12-31 | ILA3.91 | ILA29.50 | x |
| 2022-12-31 | ILA2.31 | ILA29.50 | x |
| 2023-12-31 | ILA0.98 | ILA29.50 | x |
| 2024-12-31 | ILA0.11 | ILA29.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Human Xtensions Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -788.57%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3454.29%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 2.26x
- Recent ROE (-788.57%) is below the historical average (-213.78%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -184.33% | 0.00% | 0.00x | 1.31x | ILA-30.13 Million |
| 2019 | -240.60% | -403.36% | 0.28x | 2.15x | ILA-51.20 Million |
| 2020 | -19.18% | -137.98% | 0.12x | 1.12x | ILA-43.42 Million |
| 2021 | -51.30% | -1921.97% | 0.02x | 1.15x | ILA-64.08 Million |
| 2022 | -72.18% | -1405.36% | 0.04x | 1.17x | ILA-50.77 Million |
| 2023 | -140.33% | -740.10% | 0.14x | 1.34x | ILA-39.25 Million |
| 2024 | -788.57% | -3454.29% | 0.10x | 2.26x | ILA-23.26 Million |
Industry Comparison
This section compares Human Xtensions Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $40,529,222
- Average return on equity (ROE) among peers: -29.72%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Human Xtensions Ltd (HUMX) | ILA3.29 Million | -184.33% | 0.34x | $2.12 Million |
| Allmed Solutions Ltd (ALMD) | $14.19 Million | -44.58% | 0.09x | $8.53 Million |
| Erika Carmel Ltd (BCUR) | $23.73 Million | -81.01% | 0.98x | $4.69 Million |
| Bio-View Ltd (BIOV) | $25.07 Million | 3.53% | 0.35x | $4.83 Million |
| Brainsway Ltd (BWAY) | $15.58 Million | -42.02% | 0.65x | $463.07 Million |
| Erech Finance Cahalacha Ltd (EFNC) | $-63.00K | 0.00% | 0.00x | $1.74 Million |
| Epitomee Medical Ltd (EPIT) | $34.80 Million | -16.33% | 0.16x | $62.09 Million |
| Erika Carmel-Tech Ltd (ERKA) | $9.79 Million | -59.80% | 1.98x | $5.82 Million |
| Ilex Medical (ILX) | $109.44 Million | 17.00% | 0.55x | $141.31 Million |
| Pulsenmore Ltd (PULS) | $132.23 Million | -44.29% | 0.36x | $22.89 Million |
About Human Xtensions Ltd
Human Xtensions Ltd., a medical robotics company, develops, manufactures, markets, and sells modular medical device for minimally invasive surgical operations in Israel. The company offers HandX, a handheld smart laparoscopy solution for use in laparoscopic surgeries; fenestrated grasper; monopolar hook; monopolar spatula; monopolar scissors; self-righting needle holder; and needle holder. Human … Read more